Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

06 Sep 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated September 06, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.50
Dr. Reddys Labs. 1342.30
Cipla 1360.50
Lupin 1987.90
Zydus Lifesciences 1178.95
View more..